Laurion Capital Management »

Lineage Cell Therapeutics In shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $473k 434k 1.09
2023-09-30 $1.3M 1.1M 1.18
2023-06-30 $2.8M 2.0M 1.41
2023-03-31 $3.6M 2.4M 1.50
2022-12-31 $2.8M 2.4M 1.17
2022-09-30 $2.7M 2.4M 1.13
2022-06-30 $3.8M 2.4M 1.58
2020-06-30 $11k 13k 0.88